Inhaled nitric oxide (iNO) acts as a selective pulmonary vasodilator and it is currently
approved by the FDA for the treatment of persistent pulmonary hypertension of the newborn …

Acute respiratory distress syndrome (ARDS) is a leading cause of disability and mortality
worldwide, and while no specific etiologic interventions have been shown to improve …

Pulmonary hypertension (PH) is a severe disease that affects people of all ages. It can occur
as an idiopathic disorder at birth or as part of a variety of cardiovascular and pulmonary …

Perioperative organ injury remains a medical, social and economic problem in cardiac
surgery. Patients with postoperative organ dysfunction have increases in morbidity, length of …

SEPARATION from cardiopulmonary bypass (CPB) after cardiac surgery is a progressive
transition from full mechanical circulatory and respiratory support to spontaneous …

Objective. We performed a systematic review to evaluate the effect of pharmacological
therapy of pulmonary hypertension in the perioperative setting of elective cardiac surgery …

Nitric oxide (NO), as an important gaseous medium, plays a pivotal role in the human body,
such as maintaining vascular homeostasis, regulating immune-inflammatory responses …

Hypoxemia is common in postoperative patients and is associated with prolonged hospital
stays, high costs, and increased mortality. This review discusses the postoperative …

Background We demonstrated experimentally that inhaled nitric oxide (iNO) dilates
hypoperfused arterioles, increases tissue perfusion, and improves neurological outcome …

Background The effect of nitric oxide (NO) on renal function is controversial in critical illness.
We performed a systematic meta-analysis and trial sequential analysis to determine the …